17β-estradiol-induced ACSL4 protein expression promotes an invasive phenotype in estrogen receptor positive mammary carcinoma cells.
Long chain acyl-CoA synthase-4 (ACSL4) expression has been associated with an aggressive phenotype in breast carcinoma cells, whereas its role in ERα-positive breast cancer has not been studied. ACSL4 prefers 20-carbon polyunsaturated fatty acid (PUFA) substrates, and along with other ACSLs has been associated with cellular uptake of exogenous fatty acids. 17β-estradiol induces proliferation and invasive capacities in ERα+ve breast carcinoma that is associated with modifications of cellular lipid metabolism. In this study, treatment of steroid-starved ERα-positive MCF-7 and T47D mammary carcinoma cells with 17β-estradiol resulted in increased cellular uptake of the PUFA arachidonic acid (AA) and eicosapentaenoic acid (EPA), important building blocks for cellular membranes, and increased ACSL4 protein levels. There was no change in the expression of the ACSL1, ACSL3 and ACSL6 protein isotypes. Increased ACSL4 protein expression was not accompanied by changes in ACSL4 mRNA expression, but was associated with a significant increase in the protein half-life compared to untreated cells. ERα silencing reversed the impact of 17β-estradiol on ACSL4 protein levels and half-life. Silencing of ACSL4 eliminated the 17β-estradiol-induced increase in AA and EPA uptake, as well as the 17β-estradiol-induced cell migration, proliferation and invasion capacities. ASCL4 silencing also prevented the 17β-estradiol induced increases in p-Akt and p-GSK3β, and decrease in E-cadherin expression, important events in epithelial to mesenchymal transition. Taken together, these results demonstrate that ACSL4 is a target of 17β-estradiol-stimulated ERα and is required for the cellular uptake of exogenous PUFA and the manifestation of a more malignant phenotype in ERα+ve breast carcinoma cells.
Department of Chemistry and Biochemistry, Université de Moncton, Moncton, NB E1A 3E9, Canada and.|Atlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada.
Anissa
A
Belkaid
Atlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada.
Rodney J
RJ
Ouellette
Department of Chemistry and Biochemistry, Université de Moncton, Moncton, NB E1A 3E9, Canada and.
Marc E
ME
Surette
D016718:Arachidonic Acid / Q000235:genetics; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology*; D015820:Cadherins / Q000235:genetics; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000235:genetics; D002465:Cell Movement / Q000235:genetics; D049109:Cell Proliferation / Q000235:genetics; D003066:Coenzyme A Ligases / Q000235:genetics*; D015118:Eicosapentaenoic Acid / Q000235:genetics; D058750:Epithelial-Mesenchymal Transition / Q000235:genetics; D004958:Estradiol / Q000235:genetics*; D005231:Fatty Acids, Unsaturated / Q000235:genetics; D005260:Female; D000071679:Glycogen Synthase Kinase 3 beta / Q000235:genetics; D006207:Half-Life; D006801:Humans; D050356:Lipid Metabolism / Q000235:genetics; D061986:MCF-7 Cells; D009361:Neoplasm Invasiveness / Q000235:genetics* / Q000473:pathology*; D010641:Phenotype; D011960:Receptors, Estrogen / Q000235:genetics*; D000098859:Long-Chain-Fatty-Acid-CoA Ligase
D015820:Cadherins; D005231:Fatty Acids, Unsaturated; D011960:Receptors, Estrogen; D016718:Arachidonic Acid; D004958:Estradiol; D015118:Eicosapentaenoic Acid; D000071679:Glycogen Synthase Kinase 3 beta; D003066:Coenzyme A Ligases; D000098859:Long-Chain-Fatty-Acid-CoA Ligase